Nearly 30 items of extraordinary range, from capital raises, to exec appointments, uncertainty and more.
Some new public-private stratagems for commercialization may emerge this spring and summer.
With 3686 ahead, new University and Researcher programs, weaker capital ecosystem and more
[Updated] Patient-pay firm continues its capital-raising.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: